VITROS Immunodiagnostic Products Vitamin B12 Range Verifier - In vitro diagnostic use ly. For use in verifying the calibration range of the VITROS ECi/ECiQ/3600 Immunodiagnostic Systems and the VITROS 5600/XT 7600 Integrated Systems when used for the quantitative measurement of vitamin B12 - Product Code: 6800872
Published June 12, 2024 · Recall initiated: May 8, 2024
Summary
FDA records medical device Class III recall Z-2019-2024, published June 12, 2024 and initiated May 8, 2024. Recalling firm: Ortho-Clinical Diagnostics, Inc.; Status: Ongoing; Reported quantity: 76 units; Lot: UDI-DI: 10758750000937 Lot Number: 1200 Exp. Date: 30-Sep-2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The results generated by the VITROS Immunodiagnostic Products Vitamin B12 Range Verifier Lot# 1200 RV Level 2 may cause range verification failure. The issue is detectable by the user when the product fails to meet the required range during processing of RV Level 2 of this lot. There is a potential for a delay in patient test results should the user have a need to switch to an alternate method of range verification including use of an alternate lot. As this issue affects the upper limit range verification, there is no impact to VITROS Immunodiagnostic Products Vitamin B12 assay performance. Were the assay to not perform as expected, the failure would be detectable by Quality Control. Past patient sample results are unaffected, and no review of reported results is required.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ortho-Clinical Diagnostics, Inc.
- Distributor
- Worldwide - US Nationwide and the country of Columbia.
- Lot
- UDI-DI: 10758750000937 Lot Number: 1200 Exp. Date: 30-Sep-2024
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAVITROS Chemistry Products CRP Slides- In vitro diagnostic quantitatively measures C-reactive protein (CRP)December 4, 2024
- FDAThe VITROS XT Chemistry Products ALB-TP Slides is a single device that contains both an albumin test and aAugust 28, 2024
- FDAVITROS Immunodiagnostic VITROS Folate Reagent Pack 1/2August 21, 2024
- FDAVITROS Chemistry Products Calibrator Kit 29- In-Vitor used to calibrate the VITROS 5,1 FS/4600 ChemistryJuly 10, 2024
- FDAFLIXENE, 4-7X30, 2GDS, GWT-GW. Double-Ended Slider GDS. Vascular graftJune 12, 2024
- FDABrand Name: GlideScope Core 15-inch Monitor Model/Catalog Number: 0570-0404 Product Description: SerializedJune 12, 2024
Questions about this recall
Was VITROS Immunodiagnostic Products Vitamin B12 Range Verifier - In vitro diagnostic use ly. For use in verifying the calibration range of the VITROS ECi/ECiQ/3600 Immunodiagnostic Systems and the VITROS 5600/XT 7600 Integrated Systems when used for the quantitative measurement of vitamin B12 - Product Code: 6800872 recalled?
Yes. FDA published recall Z-2019-2024 on June 12, 2024. Reported hazard: The results generated by the VITROS Immunodiagnostic Products Vitamin B12 Range Verifier Lot# 1200 RV Level 2 may cause range verification failure. The issue is detectable by the user when the product fails to meet the required range during processing of RV Level 2 of this lot. There is a potential for a delay in patient test results should the user have a need to switch to an alternate method of range verification including use of an alternate lot. As this issue affects the upper limit range verification, there is no impact to VITROS Immunodiagnostic Products Vitamin B12 assay performance. Were the assay to not perform as expected, the failure would be detectable by Quality Control. Past patient sample results are unaffected, and no review of reported results is required.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit